Saleshave been steadily increasing for years, but the rate of increase hasnow jumped. This result is above my expectations (i've had my sharesabout 3 years). Atthe AGM they said one contract OS like the one they achieved inAustralia could boost sales on a larger scale. Surely, there's a goodchance of this happening with molecular diagnostics being usedincreasingly and the advantages of the 3-base method. Doesseem an attractive investment!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.71M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18292 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 31202 | 1 |
View Market Depth
| Last trade - 10.56am 21/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |
Day chart unavailable